Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

FDA Flags Two Separate Class I Corrections for Hospital Infusion Pumps That Deliver Chemotherapy and Antibiotics

FDA posted two Class I corrections for Ivenix infusion pumps used to give chemotherapy, antibiotics and pain medicine. What patients should ask.

Medical Daily · Aug 3

Medtronic Pulls Harmony Heart Valve Delivery Catheters Over Tip Detachment Risk, but Implanted Valves Stay in Place

Medtronic recalled certain Harmony delivery catheters due to a risk of tip detachment. FDA says implanted Harmony pulmonary valves are not affected.

Medical Daily · Aug 3

FDA Says Breast Biopsy Needle Shortage Could Last into 2027 as Radiologists Triage Who Gets Scheduled First

FDA says a stereotactic breast biopsy needle shortage may last through March 2027. What patients facing a biopsy delay should know.

Medical Daily · Aug 3

From analysis to the latest developments in health,
read the most diverse news in one place.

New blood test to detect colon cancer clears FDA approval

New cases of colorectal cancer and deaths have been rising in younger adults since the mid-2000s

The Independent UK · Aug 3

The Cyclospora Outbreak Has Sickened Thousands Across The U.S.; The First Deaths Have Now Been Reported

Michigan has reported the first two deaths linked to the ongoing cyclospora outbreak, adding to a foodborne illness investigation that has sickened thousands of people and prompted recalls of iceberg lettuce distributed to restaurants and grocery stores.

International Business Times · Aug 3

FDA Names Its First Company in a Pilot That Lets Some Digital Health Devices Skip Premarket Review

The FDA selected Dexcom as the first participant in its TEMPO pilot, which pairs relaxed premarket review with real-world evidence collection.

Medical Daily · Aug 3

FDA Moves to Delete Two Food Dye Approvals That Industry Already Stopped Using

FDA finalized revoking Orange B and proposed revoking Citrus Red No. 2. Both were already abandoned by industry, so nothing leaves store shelves.

Medical Daily · Aug 3

Read news from The Economist, FT, and more,
with one subscription

Three Injectable Drug Recalls Landed on the Same Day, Including a Widely Used Cancer Drug

Three injectable medicines were recalled July 24, including a chemotherapy drug with steel particles. What patients and caregivers should know.

Medical Daily · Aug 3

Lidl US Expands Recall of Eridanous Shortbread Cookies Over Undeclared Wheat, Soy, Milk, Egg, and Coconut Allergens

Lidl US has expanded a voluntary recall of two varieties of Eridanous Shortbread Cookies due to undeclared allergens, according to an official announcement posted by the U.S. Food and Drug Administration on July 31, 2026.

Grocery Coupon Guide · Aug 3

Federal Trackers for the Powdered Milk Recall Have Not Been Updated Since May, Even as Agencies Tell Consumers to Check Back

The FDA page tracking the California Dairies recall lists seven downstream recalls and has not changed since May 8. What consumers should still check.

Medical Daily · Aug 3

Moringa Capsules Sold on Amazon Are Recalled After Supplier Testing Flagged Salmonella Before Anyone Got Sick

Zen Principle Moringa Capsules Lot A6FF4 were recalled after FDA testing found Salmonella in the raw powder. No illnesses reported. Check your bottle.

Medical Daily · Aug 3

FDA Reopens Public Comment on BHT, a Preservative Found in Cereal, Frozen Meals and Chewing Gum

FDA reopened its comment period on BHT until August 31 as part of a post-market safety review. Here is what the step does and does not mean.

Medical Daily · Aug 3

Prostate Cancer Patients Just Gained a New Radioligand Option, but Only Licensed Centers Can Give It

FDA expanded Pluvicto to hormone-sensitive metastatic prostate cancer, nearly doubling eligibility. Only licensed nuclear medicine centers can administer it.

Medical Daily · Aug 3

What Is Retatrutide? The Next-Gen GLP-1 Poised to Become the Most In-Demand Peptide

A deep dive into Retatrutide shows promise—and a lot of danger.

Marie Claire · Aug 3

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Aug 3

Patients Waiting Out Drug Shortages Have a Stake in an Obscure FDA Registration Proposal

A quiet FDA rulemaking would require more foreign drug plants to register. Better upstream visibility is how shortages get caught earlier.

Grocery Coupon Guide · Aug 2

6 Egg Carton Numbers Every Shopper Should Check After the FDA Recall

Recent federal food recalls highlighted serious safety concerns regarding commercial egg packaging. Millions of cartons faced removal from supermarket shelves due to salmonella contamination risks. Shoppers cannot rely solely on visual inspections when purchasing dairy breakfast items. Checking specific carton codes protects your family from dangerous foodborne illnesses. I will…

Medical Daily · Aug 1

Hallucinations in Alzheimer's Still Have No Approved Treatment, and the Biggest Trial Program Just Slipped to 2027

Bristol Myers Squibb delayed its Alzheimer's psychosis trial readouts to 2027. Why the treatment gap matters for families managing symptoms now.

Medical Daily · Jul 31

A Breast Cancer Drug Approved on July 14 Was Added to National Treatment Guidelines Sixteen Days Later

Gedatolisib was placed in the NCCN breast cancer guidelines as a preferred Category 1 option 16 days after FDA approval. What does that rating mean?

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Jul 31

A Detroit Health System and Michigan State Just Backed Two Medical Technology Startups, and Neither Product Is Cleared for Sale

Henry Ford Health and Michigan State named the first two investments from their $10M health venture fund. What the technologies do and do not do yet.

Medical Daily · Jul 31

FDA Gives Its Most Serious Recall Class to ResMed Astral Ventilators, but Patients Are Told Not to Stop Using Them

FDA assigned a Class 1 recall to ResMed Astral 100 and 150 ventilators. Patients are told not to stop use. Here is the guidance.

Medical Daily · Jul 31

Vaginal Estrogen Is Linked to Fewer Hospitalizations in Women with Repeat UTIs, and Most Eligible Patients Never Fill the Prescription

New database research links vaginal estrogen to lower sepsis and hospitalization rates in women with recurrent UTIs. What the evidence does and does not show.

Medical Daily · Jul 31

FDA Issues Early Alert on ResMed Astral Ventilators as Replacement Parts Run Short

FDA alerts patients that certain ResMed Astral 100 and 150 ventilators may stop therapy. Parts are limited. What families should do now.

Medical Daily · Jul 31

Two New Studies Show More Women Complete Cervical Cancer Screening When Self-Collection Is Offered

Two new studies found that more women completed cervical cancer screening when offered HPV self-collection. Here is where it is authorized in the US.

Reason · Jul 31

Rand Paul's Biosimilar Drug Bill Could Cut Costs, Speed Patient Access

The Expedited Access to Biosimilars Act enables FDA approval of pharmaceutically equivalent biologic medications.

Medical Daily · Jul 31

A Second B Cell Drug for IgA Nephropathy Was Approved in July and Two More FDA Decisions Are Due by December

FDA approved atacicept for IgA nephropathy in July. Two more drugs face decisions by year's end. Here is what is proven and what is not.

1 … 42 43 44 45

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Michigan State University

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.